Skip to main content

Sleep Disorders

September 13, 2020
A secondary analysis of a study investigating adjunctive pimavanserin for the treatment of patients with major depressive disorder found that it significantly improved insomnia and sleepiness, researchers reported at Psych Congress 2020. 
September 01, 2020
Attention-deficit/hyperactive disorder (ADHD) and narcolepsy may share genetic links, according to an analysis of polygenic risk scores published online in the journal Translational Psychiatry.
April 15, 2020
Young adults who started using cannabis regularly before age 18 were more likely to report later sleep troubles, according to a study published online in Sleep.
February 19, 2020
A label update for the insomnia drug Belsomra (suvorexant) C-IV adds study findings on its use in treating insomnia in patients with mild-to-moderate Alzheimer’s disease, drugmaker Merck announced.
January 06, 2020
The orexin receptor antagonist lemborexant (Dayvigo) has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults, Eisai Co. announced.
September 20, 2019
Treating depression in patients with comorbid insomnia is associated with improved insomnia symptoms, new research shows.
August 05, 2019
Karl Doghramji, MD, Medical Director of the Jefferson Sleep Disorders Center in Philadelphia shares tips for choosing insomnia treatments for older patients with dementia.
Back to Top